Health TrialsbyHealthPanel

Maternal and Fetal Outcomes in Elective vs Emergency Cesarean Section

ConditionMaternal and Fetal Outcomes in Elective vs Emergency Cesarean Section
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorAssiut University

About this trial

Cesarean section (CS) rates have increased substantially worldwide and in Egypt, where they now account for the majority of deliveries. Maternal and neonatal outcomes may differ between elective and emergency CS. Emergency cesarean sections are generally associated with higher maternal morbidity, including increased risks of postpartum hemorrhage, infection, blood transfusion, longer operative time, and prolonged hospital stay. Neonatal outcomes following emergency CS may also be less favorable, with higher rates of low Apgar scores, respiratory distress, and NICU admission. However, findings remain inconsistent across studies, highlighting the need for further prospective research to comprehensively compare maternal and fetal outcomes between elective and emergency cesarean deliveries.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1- Pregnant women undergoing cesarean section 2- Singleton pregnancy 3- Gestational age ≥ 28 weeks 4- Age 18-45 years

Disqualifiers

1- Multiple pregnancy 2- Known fetal anomalies 3- Intrauterine fetal demise before cesarean section 4- Severe maternal comorbidities (e.g., cardiac disease, renal failure) 5- Rupture uterus 6- patients with placenta previa or accreta spectrum

Trial population

Pregnant women undergoing cesarean section (elective or emergency) at Women's Health Hospital during the study period. Eligible participants will include women with singleton pregnancies who meet the inclusion criteria and provide complete clinical data. Maternal and neonatal outcomes will be assessed and compared between elective and emergency cesarean section groups.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • emergency cesarean section

    Procedure/Surgery

    emergency cesarean section

  • elective cesarean section

    Procedure/Surgery

    elective cesarean section

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

• Maternal morbidity composite outcome • Neonatal morbidity composite outcome

Time frame
From cesarean delivery until hospital discharge (up to 7 days postpartum).

Secondary outcomes

1

Length of stay

Time frame
From cesarean delivery until maternal hospital discharge (days), up to 7 days postpartum.
2

Operative time

Time frame
Assessed during cesarean section, from skin incision to skin closure (minutes).
3

Infection rate

Time frame
From cesarean delivery through 6 weeks postpartum.
4

Effect of confounding factors on neonatal outcomes (gestational age at delivery, type of anaesthesia)

Time frame
Assessed at birth and during neonatal hospitalization, up to 28 days after birth.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: